Tacrolimus for the treatment of primary sclerosing cholangitis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Liver international (Print)

• Publication date

  2007-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1478-3231.2007.01441.xPMID 17403184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.

  2003cited by this paper
• Tumour necrosis factor α impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis

  2001cited by this paper
• Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system.

  2000cited by this paper
• [Primary sclerosing cholangitis].

  2000influential reference
• Primary sclerosing cholangitis

  1999cited by this paper
• Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

  1996cited by this paper
• Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

  1995influential reference

• PSC and colitis: A complex relationship.

  2025cites this paper
• Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus.

  2025cites this paper
• Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?

  2024cites this paper
• Efficacy of Biologics in the Treatment of Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

  2024cites this paper
• Targeting osteopontin to treat primary sclerosing cholangitis

  2024cites this paper
• An overview of recent treatment options for primary sclerosing cholangitis

  2023cites this paper
• Secondary Sclerosing Cholangitis After Emphysematous Cholecystitis

  2023cites this paper
• The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds

  2023cites this paper
• Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease

  2023influential citation
• Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.

  2022cites this paper
• AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma.

  2022cites this paper
• Survey uncovering variations in the management of primary sclerosing cholangitis across Europe

  2022cites this paper
• Biliary Strictures: Etiologies and Medical Management

  2021cites this paper
• Primary Sclerosing Cholangitis

  2021cites this paper
• Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients

  2021cites this paper
• Review of primary sclerosing cholangitis with increased IgG4 levels

  2020cites this paper
• Long-term outcome in PSC patients receiving azathioprine: Does immunosuppression have a positive effect on survival?

  2020cites this paper
• Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities

  2020cites this paper
• Verbesserte Prognose, aber limitierte Therapieoptionen für PBC und PSC

  2019cites this paper
• Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist☆

  2019cites this paper
• Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

  2019cites this paper
• Primary Sclerosing Cholangitis: A Clinical Update

  2019cites this paper
• Primary sclerosing cholangitis

  2018cites this paper
• Emerging therapeutic targets for primary sclerosing cholangitis

  2018cites this paper
• Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

  2018cites this paper
• Inflammatory Nodules Identify Steroid-Responsive Primary Sclerosing Cholangitis

  2018cites this paper
• Clinical guidelines for primary sclerosing cholangitis 2017

  2018cites this paper
• Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis

  2017cites this paper
• Therapies for Primary Sclerosing Cholangitis: Vancomycin as a Novel Treatment Option

  2017cites this paper
• [Practice guideline autoimmune liver diseases - AWMF-Reg. No. 021-27].

  2017cites this paper
• S2k Leitlinie Autoimmune Lebererkrankungen

  2017cites this paper
• Pathogenesis and clinical spectrum of primary sclerosing cholangitis

  2017cites this paper
• Autoimmune Sclerosing Cholangitis: a Review of the Overlap between Autoimmune Hepatitis and Primary Sclerosing Cholangitis in Children

  2017cites this paper
• Emerging treatments for primary sclerosing cholangitis

  2017cites this paper
• Update on pharmacotherapies for cholestatic liver disease

  2016cites this paper
• Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management

  2016cites this paper
• New Therapeutic Strategies for Primary Sclerosing Cholangitis

  2016cites this paper
• A review of the medical treatment of primary sclerosing cholangitis in the 21st century

  2016cites this paper
• Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process

  2016cites this paper
• The Gut-Liver Axis in Primary Sclerosing Cholangitis.

  2016cites this paper
• Primary Sclerosing Cholangitis

  2016cites this paper
• Novel treatments in primary sclerosing cholangitis

  2016cites this paper
• ACG Clinical Guideline: Primary Sclerosing Cholangitis

  2015cites this paper
• An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

  2014cites this paper
• Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.

  2014cites this paper
• Medical Therapy of Hepatobiliary Diseases Associated with Ulcerative Colitis

  2014cites this paper
• Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis

  2014cites this paper
• The liver in pediatric gastrointestinal disease.

  2014cites this paper
• Diagnosis and classification of primary sclerosing cholangitis.

  2014cites this paper
• A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis

  2014cites this paper
• Primary sclerosing cholangitis: a review and update on therapeutic developments

  2013cites this paper
• Expert Review of Gastroenterology & Hepatology

  2013cites this paper
• Update on primary sclerosing cholangitis.

  2013cites this paper
• Primary Sclerosing Cholangitis: From Pathogenesis to Medical Management

  2012cites this paper
• Primary sclerosing cholangitis: etiopathogenesis and clinical management.

  2012cites this paper
• Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis

  2012cites this paper
• Genetics in primary sclerosing cholangitis.

  2012cites this paper
• Current pharmacotherapy for cholestatic liver disease

  2012cites this paper
• Primary sclerosing cholangitis: providing a safe and effective treatment

  2012cites this paper
• Current Management of Primary Sclerosing Cholangitis in Pediatric Patients

  2011cites this paper
• Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4‐associated cholangitis and overlap with autoimmune hepatitis

  2011cites this paper
• Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid‐refractory colitis

  2011cites this paper
• Genetics in primary sclerosing cholangitis.

  2011cites this paper
• New Treatment Strategies for Primary Sclerosing Cholangitis

  2011cites this paper
• [Primary sclerosing cholangitis: diagnosis, prognosis and treatment].

  2011cites this paper
• Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento

  2011cites this paper
• Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

  2010cites this paper
• 34. Primary Sclerosing Cholangitis

  2010cites this paper
• Update on primary sclerosing cholangitis.

  2010cites this paper
• Treatment options for primary sclerosing cholangitis

  2010cites this paper
• Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2009cites this paper
• High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2009cites this paper
• Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study

  2009cites this paper
• High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

  2008cites this paper
• New insights into autoimmune liver diseases

  2008cites this paper
• Clinical features and management of primary sclerosing cholangitis.

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• An update on primary sclerosing cholangitis

  2008cites this paper
• Primary sclerosing cholangitis

  2001cites this paper